US equities
|
NVDA
$152.24
▼-2.07%
MU
$701.01
▼-1.60%
AMD
$510.56
▲+1.42%
SPCX
$144.32
▲+1.85%
SNDK
$770.09
▼-3.41%
AAPL
$352.15
▲+0.07%
TSLA
$382.04
▲+0.51%
AMZN
$265.05
▲+2.78%
NVDA
$152.24
▼-2.07%
MU
$701.01
▼-1.60%
AMD
$510.56
▲+1.42%
SPCX
$144.32
▲+1.85%
SNDK
$770.09
▼-3.41%
AAPL
$352.15
▲+0.07%
TSLA
$382.04
▲+0.51%
AMZN
$265.05
▲+2.78%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Stevanato Group
Recent news which mentions Stevanato Group
EXCLUSIVE: Bexson Biomedical's CSO Says Subcutaneous Ketamine Could Treat Wide Range Of Health Issues
May 18, 2022
Tags
Ketamine
Stevanato Group
Markets
From
Benzinga
EXCLUSIVE: Bexson Biomedical Inks Agreement With Stevanato For Delivery System Of Ketamine In Pain Management
April 28, 2022
Tags
Bexson Biomedical
Biotech
effrey Becker
From
Benzinga